Imugene - Charts & Price Action (New thread), page-1164

Who cares about the rest of the market and what is the latest flavour of the month stock they chase their tails in circles over.
You and I both know we are sitting on something spectacular that is about to sign the first licensing deal with a Big Pharma the likes of Roche or GSK ... for just the first of four breakthrough vaccines/ Ov’s . You and I both know the other 3 products in our pipeline have two fifths of zero factored into the current shareprice.
As Paul Hopper just said “ I believe you are about to see the faith you’ve placed in us be acknowledged in positive fashion” . Doesn't come with any ambiguity in my eyes.
A license deal, that given the facts of the real world deals going on in ImmunoOncology , would be worth at least US$100 million in upfront payment. Potentially another $500- 700 million in progress payments as HerVax ticks more boxes towards commercialisation. Then a never ending royalty stream for 14 years.
Who cares whether it’s in 1 week, 1 month or 3 months....our trajectory is set and we are going there.
And as that old adage goes, if it’s a race between a tortoise and a hare... i’d rather be the tortoise and get there methodically without a hiccup than some freaking hare on cannabis.